an.zamora

TL2 Moderator · Kaunas

Contributes reviews on supplier material. Based in Kaunas.

Joined 21 November 2024 · last posted 5d · groups: translators

86Posts here

3Topics

2Solutions

1.5kLikes received

2kLikes given

25Badges

220Days visited

5.2kPosts read

Recent activity

Full stream

Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #57 · Compounds › Secretagogues & GH axis · 23 Jul 2026 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #20 · Clinical › Bloodwork · 17 Jul 2026 · 1 like This follows post #17 rather than contradicting it. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #70 · Compounds › Retatrutide · 17 Jul 2026 · 7 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
An 18-month record including the parts that went badly Replied, post #68 · Outcomes › Progress reports · 13 Jul 2026 · 2 likes post #67 answers the question as asked. The question underneath it is different. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is…
What is genuinely unknown about long-term amylin agonism Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Immortal time bias in a claims-database study — one year on Replied, post #7 · Evidence › Study critique · 4 Jul 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Micro-titration: a disputed topic, argued properly Replied, post #88 · Practice › Dosing & titration · 12 Jun 2026 · 1 like Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Micronutrient adequacy at low total intake Replied, post #13 · Nutrition & Training › Protein & intake · 6 Jun 2026 · 20 likes post #12 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Reading a trial's population section before its results Replied, post #86 · Evidence › Trials · 4 Jun 2026 · 20 likes I read post #84 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a…
An appeal that succeeded, with the letter structure — the long version Replied, post #42 · Access › Insurance & coverage · 2 Jun 2026 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Reading a trial's population section before its results Replied, post #65 · Evidence › Trials · 29 May 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #24 · Evidence › Trials · 12 May 2026 · 14 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…